Toyota (NYSE:TM) is reportedly weighing plans to produce the next-generation RAV4 SUV in Kentucky to counter the impact of U.S. tariffs on imported vehicles, according to sources familiar with the matter. The Japanese automaker currently builds the RAV4 in Japan, Canada, and Kentucky. It had initially planned to export the redesigned 2026 RAV4 from Japan and Canada but is now considering expanding U.S. production.
The move comes as the Trump administration enforces a 25% tariff on imported cars. Producing the RAV4 domestically would help Toyota avoid steep import costs and reduce exposure to yen volatility. While the final decision is pending, if approved, U.S. production could begin in 2027. Toyota’s manufacturing adjustments would require significant planning and retooling, delaying immediate implementation.
The RAV4 was the best-selling vehicle in the U.S. last year, surpassing Ford’s F-150, with over 475,000 units sold—about 20% of Toyota’s U.S. sales. Toyota operates 11 plants in the U.S. and manufactured around 1.3 million vehicles domestically in 2024.
Toyota stated it continuously evaluates manufacturing strategies to meet customer needs and support stable employment but declined to comment on speculation about the RAV4’s production shift.
Rising tariffs are prompting several automakers to localize production. Honda (NYSE:HMC) will produce its new Civic hybrid in Indiana instead of Mexico, while Nissan (OTC:NSANY) plans to cut Japanese output of its top-selling U.S. model by 13,000 units through July.
Toyota has invested nearly $50 billion in U.S. operations over the years. Recent talks between Japan’s trade delegation and President Trump aimed at easing auto tariffs have shown signs of progress, possibly affecting future production decisions.


Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026 



